Objectives
To evaluate whether in children born extremely preterm, indicators of sustained systemic inflammation in the first month of life are associated with cognitive impairment at school age.
Study design
873 of 966 eligible children previously enrolled in the multicenter Extremely Low Gestational Age Newborn Study from 2002–2004 were evaluated at age 10 years. We analyzed the relationship between elevated blood concentrations of inflammation-associated proteins in the first 2 weeks (“early elevations”; n=812) and the 3rd and 4th week (“late elevations”; n=532) of life with neurocognition.
Results
Early elevations of CRP, TNF-alpha, IL-8, ICAM-1, and EPO were associated with IQ values >2 SD below the expected mean (ORs: 2.0–2.3) and with moderate to severe cognitive impairment on a composite measure of IQ and executive function (ORs: 2.1–3.6). Additionally, severe cognitive impairment was associated with late protein elevations of CRP (OR:4.0; 95% CI 1.5, 10), IL-8 (OR:5.0; 1.9, 13), ICAM-1 (OR:6.5; 2.6, 16), VEGF-R2 (OR:3.2; 1.2, 8.3), and TSH (OR:3.1; 1.3, 7.3). Moderate cognitive impairment was most strongly associated with elevations of IL-8, ICAM-1, and VEGF-R2. When four or more inflammatory proteins were elevated early, the risk of having an IQ<70 and having overall impaired cognitive ability was more than doubled (ORs:2.1–2.4); the presence of four or more inflammatory protein elevated late was strongly linked to adverse cognitive outcomes (ORs:2.9–4.8).
Conclusion
EP children who had sustained elevations of inflammation-related proteins in the first postnatal month are more likely than EP peers without such elevations to have cognitive impairment at 10 years.